ProCE Banner Activity

Updates in the Management of Migraine Headache: New Options to Enhance Outcomes

Multimedia
Migraine is a debilitating neurologic disorder that occurs in about 17% of women and 6% of men in the United States. It affects all aspects of life—from work and school attendance and performance to family life, leisure time, personal relationships, and finances. Unfortunately, migraine is often underdiagnosed and undertreated. This program will review the symptoms of and diagnostic criteria for migraine, appropriate use of traditional therapies, and the role of new and emerging therapies in the management of patients with episodic and chronic migraine. 

Released: January 24, 2020

Expiration: January 22, 2021

No longer available for credit.

Share

Faculty

Nada Hindiyeh

Nada Hindiyeh, MD

Headache Neurologist

Susan M. Tiso

Susan M. Tiso, DNP, APRN, FNP-BC, FAANP

Clinical Professor, Retired
Sue & Bill Gross School of Nursing
Family Nurse Practicioner, Retired
Family Medicine 
University of California, Irvine 
Irvine, California 

Provided by

Kelly testing provider text override field
ProCE Banner

Supporters

This activity is supported by an educational grant from

Teva

Target Audience

NPs and PAs

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Identify patients with migraine based on symptomatology and diagnostic criteria
  • Implement evidence-based strategies for the treatment and prevention of episodic and chronic migraine
  • Utilize efficacy and safety evidence to identify the appropriate role of new and emerging therapies for patients with migraine

Faculty Disclosure

Primary Author

Nada Hindiyeh, MD

Headache Neurologist

Dr Hindiyeh: speaker: Amgen, Lilly.

Susan M. Tiso, DNP, APRN, FNP-BC, FAANP

Clinical Professor, Retired
Sue & Bill Gross School of Nursing
Family Nurse Practicioner, Retired
Family Medicine 
University of California, Irvine 
Irvine, California 

Dr Tiso has no relevant financial relationships to disclose.